TARA CALDWELL: Open Payments
NPI 1245876598 · NORTH CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,856 in 78 payments from 21 companies in 2025. Trend: 2023 $1,502 · 2024 $2,921 · 2025 $1,856
Food & beverage: $1,856
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $341 |
| AstraZeneca Pharmaceuticals LP | 7 | $282 |
| Novo Nordisk Inc | 6 | $229 |
| PFIZER INC. | 11 | $212 |
| Janssen Pharmaceuticals, Inc | 2 | $105 |
| Lilly USA, LLC | 6 | $100 |
| Astellas Pharma US Inc | 4 | $85 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $71 |
| Amgen Inc. | 3 | $65 |
| Exact Sciences Corporation | 3 | $63 |
Products named: BREZTRI, VRAYLAR, Ozempic, QULIPTA, SPRAVATO, MOUNJARO, Wegovy, ELIQUIS.
Industry payments across SC — which companies pay providers there.
